| Literature DB >> 11918932 |
Klaus Stark1, Matthias Günther, Christian Schönfeld, Stefan G Tullius, Ulrich Bienzle.
Abstract
Solid-organ transplant recipients are at increased risk of various infectious diseases, some of which are vaccine preventable mmunisations are among the most efficient interventions available. Solid-organ tranplant recipients would greatly benefit from effective immunisations, provided the recommendations are based on a careful risk-benefit analysis in which the effectiveness of the vaccine is weighed against possible adverse reactions, including graft rejection. In this review, we summarise the data from studies on relevant immunisations in solid-organ transplant recipients. The major issues are the immunogenicity and safety of immunisations, the factors associated with poor immune response, and recommendations for immunisation schemes.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11918932 DOI: 10.1016/S0140-6736(02)08028-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321